25
CNS Control of Metabolism and Growth

CNS Control of Metabolism and Growth

  • Upload
    hayden

  • View
    31

  • Download
    0

Embed Size (px)

DESCRIPTION

CNS Control of Metabolism and Growth . Hypothalamic-Anterior Pituitary Axis. Hypothalamic neurons secrete releasing factor or release-inhibiting factor (usually a small peptide) into hypothalamic-anterior pituitary portal system - PowerPoint PPT Presentation

Citation preview

Page 1: CNS Control of Metabolism and Growth

CNS Control of Metabolism and Growth

Page 2: CNS Control of Metabolism and Growth

Hypothalamic-Anterior Pituitary Axis

• Hypothalamic neurons secrete releasing factor or release-inhibiting factor (usually a small peptide) into hypothalamic-anterior pituitary portal system

• Releasing factor targets specific cell population in ant. pituitary, which releases ant.pituitary hormone (a large peptide or glycopeptide) into general circulation.

• In many cases, the ant. pituitary hormone is a tropic hormone that controls the activity of an endocrine gland

Page 3: CNS Control of Metabolism and Growth

The hypothalamic -hypophyseal

control systems

Page 4: CNS Control of Metabolism and Growth

Major Anterior Pituitary HormonesHormone Target Effects

Growth Hormone (Somatotropin)

Whole Body Growth, substrate mobilization – most effects mediated by tissue-specific somatomedins

Thyroid-stimulating H. TSH

Thyroid Increase secretion of thyroxine (T4) – increase basal metabolism

Adrenocorticotropin (ACTH)

Adrenal Cortex Increase secretion of cortisol (mainly); aldosterone and androgen (secondarily)

Gonadotropins(Luteinizing H.,Follicle-Stimulating H.)

Gonads Gonadal steroids (estrogen, progesterone, testosterone); gametogenesis; sexuald differentiation

Prolactin Breasts Milk production

Melanocyte-stimulating H.

Melanocytes in skin

Increase in pigmentation – for animals that undergo seasonal color change

Page 5: CNS Control of Metabolism and Growth

Negative-feedback control loops

hypothalamus

Anterior pituitary

Peripheral gland

Effector organs

Tropic hormone

Final Hormone

Page 6: CNS Control of Metabolism and Growth

Thyroid Hormones are derivatives of tyrosine

Page 7: CNS Control of Metabolism and Growth

Control Factors for plasma levels of T4 and T3

• Increased TSH secretion:– Cold adaptation (non-tropical mammals)– Birth (humans)

• Increased conversion of T4 to T3

(peripheral deiodinase activity)– Food – especially carbohydrate

Page 8: CNS Control of Metabolism and Growth

Metabolic Effects of T3 and T4

• Action via nuclear receptors controlling the expression of specific genes

• Although there is about 50X more T4 in circulation than T3, T3 is much more effective than T4

• Essential for normal growth and developmentBoth hormone forms increase basal metabolic rate and

heat production by stimulating futile cycles of catabolism-anabolism– Na/K pump – Na and K leak– Gluconeogenesis – glycolysis– Protein synthesis – protein catabolism– Lipogenesis-lipolysis

Page 9: CNS Control of Metabolism and Growth

Human Energy Budget

basal metabolismExercisethermogenesis

Age, sex, lean body mass, genetic factors

Cold exposure, diet, stress, energy requirements associated with digestion

Total of about 2,500 Kcal/day

Page 10: CNS Control of Metabolism and Growth

Thyroid Disorders

• Hyperthyroidism (Grave’s Disease) – autoantibody to TSH receptor acts like TSH - thyroid enlarges,

(goiter) – hypermetabolic state with heart and CNS symptoms,

exopthalmia – ‘Thyroid storms’ may occur– diagnosis: high T4,low T3, low TSH

• Hypothyroidism – Idiopathic: atrophy preceded by inflammation; TSH levels high– Iodine-deficiency – thyroid unable to synthesize T4, so TSH

levels elevated – thyroid hyperplasia leads to goiter– Symptoms: weight gain, cold intolerance, bradycardia, lethargy,

retarded growth and mental development– Diagnosis: T4 low, T3 high

Page 11: CNS Control of Metabolism and Growth

Growth Hormone (somatotropin or hGH)

• Effects: – increased protein synthesis – increased carbohydrate and lipid mobilization

• i.e., hGH is potentially diabetogenic

– Action by inducing liver and other tissues to synthesize specific somatomedins or insulin-like growth factors,

• somatomedin C (IGF I) which stimulates cartilage growth • IGF2 epidermal growth factor• NGF nerve growth factor

Page 12: CNS Control of Metabolism and Growth

Control of hGH secretion

Hypothalamus

GHrh (ghrelin) GHrih (somatostatin)

Ant. Pituitary

hHG

IGF1

Developmental program, sleep, stress, starvation, exercise, protein meal

Obesity blunts effect of GHrh hGH secretion occurs in

brief pulses, so that it is not possible to have accurate information about secretion rates on the basis of single plasma samples. In both children and adults, hGH secretion is promoted by dietary protein.

Page 13: CNS Control of Metabolism and Growth

Daily Pattern of hGH Release

• In adolescence, almost all daily secretion occurs just after sleep begins

• Secretion continues in adulthood, but at much lower levels - triggered by eating a protein meal or by exercise – levels are almost unmeasureable in bed-resting subjects after an overnight fast.

Page 14: CNS Control of Metabolism and Growth

Long-Bone Growth is controlled by IGF I and Gonadal Steroids

• Growth in stature is result of elongation of bone shafts at epiphyseal plate (cartilage), stimulated by IGF I

• Growth termination occurs when cartilage is replaced by solid bone (epiphyseal closure)

• Bone elongation is stimulated by gonadal steroid – especially testosterone – but gonadal steroid also tends to terminate bone growth by accelerating epiphyseal closure – for this reason, hypogonadism or castration before puberty tends to increase stature.

Page 15: CNS Control of Metabolism and Growth

hGH and IGF-1 have effects throughout the life cycle

• Age 3-4 through puberty: IGF-1 levels rise continuously, peaking at about age 12 in girls and age 15 in boys, simultaneous with the highest rate of increase in stature.

• Post adolesence: hGH and IGF-1 levels gradually fall by about 2/3 between teens and middle life, but hGH and IGF-1 remain important regulators of body composition. In adults, supplementation with recombinant hGH can cause significant increases in muscle mass, decrease in fat mass, and metabolic rate. However, increased levels of IGF-1 may also promote cancer and diabetes.

Page 16: CNS Control of Metabolism and Growth

growth defects related to hGH: at least 5 basic types

• Defects of hGh secretion– Hyperpituitary giantism– Hypopituitary dwarfism

– Acromegaly – excessive growth of flat bones resulting from hGH excess after adult growth has been completed – people with acromegaly frequently have diabetes-like symptoms as well

• hGH receptor defect operative throughout life – Laron dwarfism

• Deficiency of IGF I or IGF I receptor around the time of puberty with no deficiency of IGF II – short stature but normal body proportions.– Efe pygmies of northeast Zaire – decreased expression of IGF I

receptor starts in late childhood – rise in testosterone levels at puberty is normal but does not lead to growth spurt.

– But not all pygmy populations appear to share this mechanism.

Result from excess or deficiency starting in childhood

Page 17: CNS Control of Metabolism and Growth

Laron dwarfism

There are about 300 Laron dwarfs in the world – about 100 of them are in Ecuador. Laron dwarfs are characterized by low levels of IGF-1 (the result of a hypofunctional hGH receptor) and high levels of hGH. They are almost free of cancer and diabetes and have enhanced longevity.

Page 18: CNS Control of Metabolism and Growth

The little women of Loja – another form of Laron-type dwarfism also found in Ecuador

In this form, the trait is recessive sex-linked male-lethal – almost all affected males die before birth, and thus the number of female children in families where the mother is a carrier tends to be twice the number of males. As for the classical form of Laron dwarfism, hGH levels are high and IGF-1 and IGF-2 levels are barely detectible in most patients.

Page 19: CNS Control of Metabolism and Growth

How did these variant genes for hGH receptors get to Ecuador? Paintings can provide a clue

• The Spanish artist Diego Velasquez (1599-1660) was painting the court of Philip IV around the time that Spain was colonizing the Americas. His paintings include several recognizable Laron dwarfs. The custom of keeping dwarfs as court entertainment was continued in Spain long after it had vanished from more progressive European courts. One might hypothesize that Spanish colonists carried genes for dwarfism to the New World.

Page 20: CNS Control of Metabolism and Growth

The Dwarf Francisco Lezcano, Called "El Nino de Vallecas" c. 1642-45 (130 Kb); Oil on canvas, 107 x 83 cm (42 1/8 x 32 5/8 in); Museo del Prado, Madrid; No. 1204

Page 21: CNS Control of Metabolism and Growth

The Dwarf Sebastian de Morra (90 Kb); Museo del Prado, Madrid

Page 22: CNS Control of Metabolism and Growth

Las Meninas (Maids of Honor) 1656-57 (120 Kb); Museo del Prado, Madrid

The little girl in white is the Infanta Margarita Teresa, who was married at quite a young age to her uncle Leopold I, the Holy Roman Emperor.

Page 23: CNS Control of Metabolism and Growth

Growth defects unrelated to the GHrh-hGH-IGF axis

Achondroplastic dwarves – the most common type of dwarfism - defect in conversion of cartilage to bone – results from a single point mutation inherited as a dominant autosomal trait. There are a number of related disorders of osteogenesis.

Page 24: CNS Control of Metabolism and Growth

GH is not the only hormone needed for normal growth

• Thyroid hormones• Sex steroids – the effect is paradoxical – bone

growth is stimulated but so is epiphyseal closure – most of the time, the dominant effect is to narrow the time window in which the growth spurt of puberty can occur.

• Glucocorticoids• Insulin – in lower vertebrates, insulin is the

growth hormone

Page 25: CNS Control of Metabolism and Growth

Pharmacological growth control raises ethical and social issues

• In men, stature correlates strongly with perceived attractiveness, social success and economic success.

• Above-average stature is a prerequisite for success in certain sports.

• Recombinant hGH is now readily available• Should pharmaceutical firms designate some fraction of the

population of otherwise healthy children as growth-deficient and promote prescription of hGH for these children to increase sales?

• Should parents be allowed to obtain hGH prescriptions for their healthy children to promote their potential for success in the NBA, or in life generally?

• Should ‘normal’ aging be regarded as a disease, and older adults be able to get hGH to mitigate the effects of aging?